Austar Lifesciences Ltd
06118
Company Profile
Business description
Austar Lifesciences Ltd is engaged in providing integrated engineering solutions to pharmaceutical manufacturers and research institutes, as well as manufacturing and distribution of pharmaceutical equipments and consumables in the People’s Republic of China. The company’s segments include Integrated Process and Packaging Equipment & Systems (IPS); Consulting, Digitalization and Construction (CDC); and Life Science Equipment and Consumables (SIC). Geographically, it derives the majority of its revenue from Mainland China.
Contact
No.1018 Changning Road
Rooms 2010-2013, 20th Floor
Changning District
Shanghai
CHNT: +86 4008121586
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
1,445
Stocks News & Analysis
stocks
Netflix: A business that’s nearly flawless
Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks
Trump’s US dollar assault is fuelling CBA’s rise
A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.
stocks
Insignia Financial: Revised deal still attractive
The offer price is well above our fair value.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,979.40 | 22.00 | -0.24% |
| CAC 40 | 7,813.97 | 36.46 | -0.46% |
| DAX 40 | 24,292.55 | 51.73 | 0.21% |
| Dow JONES (US) | 44,766.33 | 243.96 | -0.54% |
| FTSE 100 | 9,144.95 | 83.46 | 0.92% |
| HKSE | 25,667.18 | 129.11 | 0.51% |
| NASDAQ | 21,059.31 | 39.29 | 0.19% |
| Nikkei 225 | 41,826.34 | 655.02 | 1.59% |
| NZX 50 Index | 12,805.13 | 11.07 | 0.09% |
| S&P 500 | 6,367.96 | 9.05 | 0.14% |
| S&P/ASX 200 | 8,709.40 | 27.80 | -0.32% |
| SSE Composite Index | 3,605.73 | 23.43 | 0.65% |